Dow Valuation
Is DOW1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DOW1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DOW1 * (MX$1017) is trading below our estimate of fair value (MX$1617.65)
Significantly Below Fair Value: DOW1 * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DOW1 *?
Other financial metrics that can be useful for relative valuation.
What is DOW1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$39.42b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.2x |
Enterprise Value/EBITDA | 10.5x |
PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does DOW1 *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 19.1x | ||
CYDSASA A Cydsa. de | 5.4x | 16.0% | Mex$9.9b |
GMEXICO B Grupo México. de | 12.2x | 7.2% | Mex$731.9b |
CEMEX CPO CEMEX. de | 44.2x | 32.3% | Mex$176.6b |
LYB LyondellBasell Industries | 14.4x | 12.0% | US$31.1b |
DOW1 * Dow | 32.6x | 25.0% | Mex$39.4b |
Price-To-Earnings vs Peers: DOW1 * is expensive based on its Price-To-Earnings Ratio (32.6x) compared to the peer average (19.1x).
Price to Earnings Ratio vs Industry
How does DOW1 *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
Price-To-Earnings vs Industry: DOW1 * is expensive based on its Price-To-Earnings Ratio (32.6x) compared to the Global Chemicals industry average (21.8x).
Price to Earnings Ratio vs Fair Ratio
What is DOW1 *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 32.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DOW1 *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,017.00 | Mex$1,042.86 +2.5% | 6.1% | Mex$1,153.08 | Mex$881.77 | n/a | 20 |
Jun ’25 | n/a | Mex$1,042.86 0% | 6.1% | Mex$1,153.08 | Mex$881.77 | n/a | 20 |
May ’25 | n/a | Mex$1,040.57 0% | 6.4% | Mex$1,157.36 | Mex$885.04 | n/a | 21 |
Apr ’25 | Mex$951.00 | Mex$972.03 +2.2% | 7.9% | Mex$1,130.94 | Mex$864.84 | n/a | 20 |
Mar ’25 | n/a | Mex$985.48 0% | 7.4% | Mex$1,160.49 | Mex$887.44 | n/a | 20 |
Feb ’25 | n/a | Mex$995.37 0% | 7.3% | Mex$1,171.13 | Mex$895.57 | n/a | 20 |
Jan ’25 | n/a | Mex$961.32 0% | 7.6% | Mex$1,184.59 | Mex$841.23 | n/a | 20 |
Dec ’24 | n/a | Mex$974.40 0% | 7.8% | Mex$1,205.02 | Mex$855.74 | n/a | 20 |
Nov ’24 | Mex$879.35 | Mex$1,024.50 +16.5% | 7.9% | Mex$1,264.14 | Mex$897.72 | n/a | 20 |
Oct ’24 | n/a | Mex$965.10 0% | 9.6% | Mex$1,233.08 | Mex$804.93 | n/a | 21 |
Sep ’24 | n/a | Mex$969.43 0% | 9.8% | Mex$1,231.03 | Mex$803.59 | n/a | 22 |
Aug ’24 | n/a | Mex$948.23 0% | 9.6% | Mex$1,201.06 | Mex$784.03 | n/a | 23 |
Jul ’24 | n/a | Mex$975.11 0% | 9.9% | Mex$1,229.56 | Mex$802.63 | n/a | 25 |
Jun ’24 | n/a | Mex$1,027.77 0% | 10.5% | Mex$1,273.56 | Mex$831.35 | n/a | 24 |
May ’24 | Mex$975.00 | Mex$1,052.39 +7.9% | 10.6% | Mex$1,299.28 | Mex$848.14 | n/a | 22 |
Apr ’24 | n/a | Mex$1,072.41 0% | 12.1% | Mex$1,328.14 | Mex$811.64 | Mex$951.00 | 22 |
Mar ’24 | n/a | Mex$1,096.49 0% | 13.1% | Mex$1,360.09 | Mex$736.72 | n/a | 22 |
Feb ’24 | Mex$990.00 | Mex$1,063.01 +7.4% | 14.0% | Mex$1,355.72 | Mex$734.35 | n/a | 22 |
Jan ’24 | n/a | Mex$1,017.77 0% | 14.6% | Mex$1,366.02 | Mex$772.10 | n/a | 22 |
Dec ’23 | n/a | Mex$985.10 0% | 12.6% | Mex$1,281.79 | Mex$769.08 | n/a | 22 |
Nov ’23 | n/a | Mex$985.10 0% | 12.6% | Mex$1,281.79 | Mex$769.08 | Mex$879.35 | 22 |
Oct ’23 | n/a | Mex$1,094.69 0% | 12.8% | Mex$1,308.00 | Mex$885.41 | n/a | 20 |
Sep ’23 | n/a | Mex$1,172.04 0% | 10.9% | Mex$1,421.83 | Mex$901.16 | n/a | 19 |
Aug ’23 | Mex$1,070.00 | Mex$1,224.90 +14.5% | 11.4% | Mex$1,535.16 | Mex$982.50 | n/a | 19 |
Jul ’23 | Mex$1,037.65 | Mex$1,389.59 +33.9% | 11.2% | Mex$1,602.56 | Mex$981.57 | n/a | 19 |
Jun ’23 | Mex$1,375.73 | Mex$1,453.84 +5.7% | 9.0% | Mex$1,670.51 | Mex$1,173.33 | n/a | 19 |
Analyst Forecast: Target price is less than 20% higher than the current share price.